North America Drug Eluting Balloons (DEB) Market was valued at USD 0.35 Billion in 2022 and is projected to reach USD 0.75 Billion by 2030, growing at a CAGR of 9.9% from 2024 to 2030.
Drug-eluting balloons (DEBs) have revolutionized cardiovascular treatments in North America, offering a minimally invasive solution for patients with coronary and peripheral artery diseases. These innovative devices release antiproliferative drugs directly into the arterial wall, effectively reducing restenosis rates and improving patient outcomes.
In 2024, the North American DEB market was valued at approximately USD 1.38 billion, with projections indicating growth to around USD 3.94 billion by 2034, reflecting a compound annual growth rate (CAGR) of 11.06%. This substantial growth is driven by the increasing prevalence of cardiovascular diseases, a rising preference for minimally invasive procedures, and continuous technological advancements in DEB design and drug formulations.
Key applications of DEBs in North America include:
Coronary Artery Disease (CAD): DEBs are utilized to treat narrowed coronary arteries, delivering medication to prevent re-narrowing without the need for permanent stents.
Peripheral Artery Disease (PAD): DEBs address blockages in peripheral arteries, particularly in the lower extremities, offering an effective alternative to traditional angioplasty and stenting.
Industry requirements for DEBs encompass several critical factors:
Regulatory Approvals: Manufacturers must navigate stringent regulatory pathways to ensure DEB safety and efficacy, with the U.S. Food and Drug Administration (FDA) playing a pivotal role in market authorization.
Technological Innovation: Continuous research and development are essential to enhance drug coatings, balloon materials, and delivery mechanisms, thereby improving clinical outcomes and expanding therapeutic indications.
Reimbursement Policies: Favorable reimbursement frameworks are crucial for widespread adoption, necessitating collaboration between industry stakeholders and healthcare payers to establish cost-effective solutions.
Leading companies in the North American DEB market include Medtronic, Boston Scientific Corporation, Becton, Dickinson and Company, Terumo Corporation, and Koninklijke Philips N.V. These organizations are at the forefront of developing advanced DEB technologies and expanding their applications across various cardiovascular interventions.
As a healthcare professional, I have witnessed firsthand the transformative impact of DEBs on patient care. The ability to deliver targeted therapy without leaving a permanent implant has not only reduced complication rates but also enhanced patient satisfaction and recovery times. The North American Drug Eluting Balloons (DEB) Market continues to evolve, driven by innovation and a commitment to improving cardiovascular health outcomes.
Get an In-Depth Research Analysis of the North America Drug Eluting Balloons (DEB) Market Size And Forecast [2025-2032]
B. Braun
Medtronic
Boston Scientific
BD
Yinyi
Philips
Eurocor
Aachen Resonance
Biotronic
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the North America Drug Eluting Balloons (DEB) Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the North America Drug Eluting Balloons (DEB) Market
Catheterization Laboratory
Hospital
Based on Types the Market is categorized into Below types that held the largest Drug Eluting Balloons (DEB) market share In 2023.
Peripheral DEBs
Coronary DEBs
North America (United States, North America and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Drug Eluting Balloons (DEB) Market Research Analysis
1. Introduction of the North America Drug Eluting Balloons (DEB) Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. North America Drug Eluting Balloons (DEB) Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. North America Drug Eluting Balloons (DEB) Market, By Type
6. North America Drug Eluting Balloons (DEB) Market, By Application
7. North America Drug Eluting Balloons (DEB) Market, By Geography
North America
Europe
Asia Pacific
Rest of the World
8. North America Drug Eluting Balloons (DEB) Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading North America Research and Consulting firm servicing over 5000+ North America clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/